KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Gross Margin (2017 - 2025)

Abbott Laboratories' Gross Margin history spans 18 years, with the latest figure at 56.2% for Q1 2026.

  • On a quarterly basis, Gross Margin fell 67.0% to 56.2% in Q1 2026 year-over-year; TTM through Mar 2026 was 56.26%, a 45.0% increase, with the full-year FY2025 number at 56.42%, up 101.0% from a year prior.
  • Gross Margin hit 56.2% in Q1 2026 for Abbott Laboratories, down from 57.05% in the prior quarter.
  • Over the last five years, Gross Margin for ABT hit a ceiling of 58.07% in Q1 2022 and a floor of 54.48% in Q4 2022.
  • Historically, Gross Margin has averaged 55.8% across 5 years, with a median of 55.57% in 2023.
  • The widest YoY moves for Gross Margin: up 457bps in 2022, down -399bps in 2022.
  • Tracing ABT's Gross Margin over 5 years: stood at 54.48% in 2022, then rose by 2bps to 55.51% in 2023, then fell by -1bps to 54.97% in 2024, then rose by 4bps to 57.05% in 2025, then fell by -1bps to 56.2% in 2026.
  • Business Quant data shows Gross Margin for ABT at 56.2% in Q1 2026, 57.05% in Q4 2025, and 55.36% in Q3 2025.